A Multi-center Prospective Study on the Oncological and Reproductive Outcomes and Quality of Life in Young Woman After Fertility-sparing Treatment of Endometrial Cancer and Endometrial Intraepithelial Hyperplasia

We will investigate the safety and efficiency of fertility-sapring treatment in ypung women witg endometrial cancer and endometrial intraepithelial hyperplasia

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Endometrial Cancer Endometrial Hyperplasia Endometrial Intraepithelial Neoplasia Endometrial Neoplasms Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Fertility-sparing Surgery Genital Diseases Genital Diseases, Female Genital Neoplasms, Female Neoplasms Neoplasms by Site Urogenital Diseases Urogenital Neoplasms Uterine Diseases Uterine Neoplasms

Age range

18 year–45 year

Sex eligibility

Female

Study type

Observational

About this study

A multi-center prospective study on the oncological and reproductive outcomes and quality of life in young woman after fertility-sparing treatment of endometrial cancer and endometrial intraepithelial hyperplasia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Fertility sparing treatment of EC and EIN.
18-45 Years old
From start study (Jan 2025 - end study Jan 2028)
All centras in Sweden

Exclusion criteria

Not English och Swedish speaking

Treatment and study plan

Primary outcomes

Relaps of endometrial cancer or EIN after fertility-sparing treatment

Time frame: from enrollment to 2 years after fertility-sparing treatment

Relaps of endometrial cancer or EIN after fertility-sparing treatment

Secondary outcomes

Live birth rate in women that has been treated with fertility-sparing treatment for EC or EIN

Time frame: From start of study to 2 years after fertility-sparing treatment

Live birth rate in women that has been treated with fertility-sparing treatment for EC or EIN

Study contacts

Contact information is provided by the study sponsor or research team.

Charlotta CR Riese, MD, PHD-student

CONTACT

[email protected]

+46703440206

Kenny Rodriguez Wallberg, Proffessor

CONTACT

[email protected]

+46 73546 10 71

Sponsors and collaborators

Lead sponsor

Region Stockholm

Other Gov

Registry information

Acronym: PreFerEC/EIN

Important dates

Study start: 2025
Primary completion: 2028
Study completion: 2030
First posted: Dec 20, 2024
Registry last updated: Dec 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting